MFAM
WST icon

Motley Fool Asset Management’s West Pharmaceutical WST Stock Holding History

Motley Fool Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24M Sell
17,372
-702
-4% -$215K 0.24% 77
2026
Q1 		$4.53M Sell
18,074
-1,092
-6% -$272K 0.19% 102
2025
Q4 		$5.27M Sell
19,166
-1,386
-7% -$379K 0.21% 105
2025
Q3 		$5.39M Sell
20,552
-1,001
-5% -$243K 0.22% 93
2025
Q2 		$4.72M Buy
+21,553
New +$4.61M 0.22% 91

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Motley Fool Asset Management's WST Position: Q2 2026 in Review

Motley Fool Asset Management reduced its West Pharmaceutical (WST) stake by 3.9% in Q2 2026, selling an estimated $215K and leaving 17,372 shares worth $6.24M. The position accounts for 0.24% of the portfolio, ranked #77.

Motley Fool Asset Management first reported a position in WST in Q2 2025 and has held it in 5 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Motley Fool Asset Management held 17,372 shares of West Pharmaceutical worth $6.24M as of Q2 2026.
  • Motley Fool Asset Management sold 702 West Pharmaceutical shares in Q2 2026, an estimated $215K.
  • West Pharmaceutical made up 0.24% of Motley Fool Asset Management's portfolio in Q2 2026, its #77 holding.
  • Motley Fool Asset Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.